PERIVENTRICULAR LEUKOMALACIA

This adverse event was reported 283 times

These drugs are most commonly taken by patients reporting PERIVENTRICULAR LEUKOMALACIA:

# Drug Count
0 RITONAVIR 21
1 INDOMETHACIN 18
2 ACETAMINOPHEN 16
3 CYTARABINE 16
4 AMPHOTERICIN B 15
5 CEFUROXIME 14
6 MAGNESIUM 14
7 MEROPENEM 14
8 RITONAVIR 100 MG 14
9 ACETAMINOPHEN 500MG 13
See all common drugs associated with PERIVENTRICULAR LEUKOMALACIA

PERIVENTRICULAR LEUKOMALACIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DINOPROSTONE 13 0.0159
1 IBUPROFEN LYSINE 4 0.0070
2 BUTALBITAL, ASPIRIN, AND CAFFEINE 1 0.0058
3 DAUNORUBICIN HYDROCHLORIDE 9 0.0055
4 BERACTANT 2 0.0054
5 OXYTOCIN 13 0.0043
6 ENALAPRILAT 1 0.0039
7 PORACTANT ALFA 2 0.0027
8 ECONAZOLE NITRATE 2 0.0021
9 HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN 1 0.0021
See all drugs enriched for association with PERIVENTRICULAR LEUKOMALACIA

PERIVENTRICULAR LEUKOMALACIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Oxytocic [EPC] 13 0.0043
1 Surfactant [EPC] 3 0.0026
2 Lipid-based Polyene Antifungal [EPC] 15 0.0012
3 Methylating Agent [EPC] 1 0.0010
4 Protease Inhibitor [EPC] 21 0.0005
5 alpha-1 Adrenergic Agonist [EPC] 2 0.0005
6 Penem Antibacterial [EPC] 14 0.0004
7 Polyene Antifungal [EPC] 16 0.0004
8 Lipid Emulsion [EPC] 1 0.0004
9 Cytochrome P450 3A Inhibitor [EPC] 21 0.0003
See all drug classes enriched for association with PERIVENTRICULAR LEUKOMALACIA